Anti-Tuberin antibody [EPR22886-235]
- KO Validated
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal Tuberin antibody. Suitable for IP, WB and reacts with Human, Mouse samples.
View Alternative Names
TSC4, TSC2, Tuberin, Tuberous sclerosis 2 protein
- IP
Unknown
Immunoprecipitation - Anti-Tuberin antibody [EPR22886-235] (AB255612)
Tuberin was immunoprecipitated from 0.35 mg HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate 10μg with ab255612 at 1/30 dilution (2μg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab255612. VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1/5000 dilution.
Lane 1 : HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate 10μg
Lane 2 : ab255612 IP in HeLa whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab255612 in HeLa whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 3 minutes.
All lanes:
Immunoprecipitation - Anti-Tuberin antibody [EPR22886-235] (ab255612)
Predicted band size: 201 kDa
Observed band size: 200 kDa
false
- WB
Lab
Western blot - Anti-Tuberin antibody [EPR22886-235] (AB255612)
Western blot : Anti-TSC2 antibody [EPR22886-235] (ab255612) staining at 1/1000 dilution, shown in green; Mouse anti-CANX [CANX/1543] (ab238078) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab255612 was shown to bind specifically to TSC2. A band was observed at 200 kDa in wild-type A549 cell lysates with no signal observed at this size in TSC2 knockout cell line. To generate this image, wild-type and TSC2 knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-Tuberin antibody [EPR22886-235] (ab255612) at 1/1000 dilution
Lane 1:
Wild-type A549 cell lysate at 20 µg
Lane 2:
TSC2 knockout A549 cell lysate at 20 µg
Lane 3:
Wild-type HAP1 cell lysate at 20 µg
Lane 4:
TSC2 knockout HAP1 cell lysate at 20 µg
Secondary
All lanes:
Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
false
- WB
Lab
Western blot - Anti-Tuberin antibody [EPR22886-235] (AB255612)
The molecular weight observed is consistent with what has been described in the literature (PMID : 30774414; 10335945).
ab255612 was shown to specifically react with Tuberin in wild-type HAP1 cells as signal was lost in Tuberin knockout cells. Wild-type and Tuberin knockout samples were subjected to SDS-PAGE. ab255612 and ab129002 (Recombinant Anti-Vinculin antibody [EPR8185]) were incubated 1 hour at room temperature at 1/1000 dilution and 1/200,000 dilution respectively. Blots were developed with Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) secondary antibody at 1/20,000 dilution for 1 hour at room temperature before imaging. The blot was developed on a BIO-RAD® ChemiDoc™ MP instrument using the ECL technique.
Blocking and dilution buffer : 5% NFDM/TBST.
Exposire times.
Lanes 1-3 : 81 seconds; Lane 4 : 3 minutes.
All lanes:
Western blot - Anti-Tuberin antibody [EPR22886-235] (ab255612) at 1/1000 dilution
Lane 1:
Wild-type HAP1 whole cell lysate at 20 µg
Lane 2:
Tuberin knockout HAP1 whole cell lysate at 20 µg
Lane 3:
HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate at 20 µg
Lane 4:
HepG2 (human hepatocellular carcinoma epithelial cell), whole cell lysate at 20 µg
Lane 5:
A549 (human lung carcinoma epithelial cell), whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 201 kDa
Observed band size: 200 kDa
false
- WB
Lab
Western blot - Anti-Tuberin antibody [EPR22886-235] (AB255612)
Blocking and dilution buffer : 5% NFDM/TBST.
The molecular weight observed is consistent with what has been described in the literature (PMID : 30774414; 10335945).
This blot was developed using a higher sensitivity ECL substrate.
All lanes:
Western blot - Anti-Tuberin antibody [EPR22886-235] (ab255612) at 1/1000 dilution
Lane 1:
Human testis tissue lysate at 20 µg
Lane 2:
C2C12 (mouse myoblasts myoblast), whole cell lysate at 20 µg
Secondary
Lane 1:
Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/1000 dilution
Lane 2:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 201 kDa
Observed band size: 200 kDa
false
Exposure time: 3min
- WB
Lab
Western blot - Anti-Tuberin antibody [EPR22886-235] (AB255612)
Blocking and dilution buffer : 5% NFDM/TBST.
The molecular weight observed is consistent with what has been described in the literature (PMID : 30774414; 10335945).
All lanes:
Western blot - Anti-Tuberin antibody [EPR22886-235] (ab255612) at 1/1000 dilution
Lane 1:
Mouse brain tissue lysate at 20 µg
Lane 2:
RAW264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage), whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 201 kDa
Observed band size: 200 kDa
false
Exposure time: 3min
Related conjugates and formulations (1)
-
Anti-Tuberin antibody [EPR22886-235] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Tuberin helps control cell size and proliferation. It does this by modulating the mTOR signaling pathway. This modulation is essential for maintaining cellular homeostasis and energy balance particularly under conditions of nutrient scarcity. Tuberin as part of the TSC1-TSC2 complex also influences cell cycle progression and protein synthesis. Its functions are vital in preventing abnormal cell growth and division which is particularly important in organs where rapid cell turnover occurs.
Pathways
Tuberin plays a central role in the mTOR signaling pathway which affects cell growth autophagy and metabolism. It directly interacts with hamartin (TSC1) to form the TSC1-TSC2 complex which regulates Rheb activity. By inhibiting Rheb Tuberin helps control the mTORC1 pathway linking it to signals such as growth factors stress energy status and amino acid availability. This coordination is important for the proper balance between cell growth and catabolism.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com